215 related articles for article (PubMed ID: 21234728)
1. Laparoscopic and image-guided radiofrequency ablation of renal tumors: patient selection and outcomes.
Castle SM; Gorbatiy V; Ekwenna O; Leveillee RJ
Curr Urol Rep; 2011 Apr; 12(2):100-6. PubMed ID: 21234728
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.
Ramirez D; Ma YB; Bedir S; Antonelli JA; Cadeddu JA; Gahan JC
J Endourol; 2014 Mar; 28(3):330-4. PubMed ID: 24156661
[TBL] [Abstract][Full Text] [Related]
3. Image-guided percutaneous ablation of renal tumors: outcomes, technique, and application in urologic practice.
Mues AC; Landman J
Curr Urol Rep; 2010 Feb; 11(1):8-14. PubMed ID: 20425631
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
[TBL] [Abstract][Full Text] [Related]
5. Renal tumor radiofrequency ablation.
Slabaugh TK; Ogan K
Minerva Urol Nefrol; 2005 Dec; 57(4):261-9. PubMed ID: 16247348
[TBL] [Abstract][Full Text] [Related]
6. Management and outcomes of tumor recurrence after focal ablation renal therapy.
Breda A; Anterasian C; Belldegrun A
J Endourol; 2010 May; 24(5):749-52. PubMed ID: 20443716
[TBL] [Abstract][Full Text] [Related]
7. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.
Leveillee RJ; Castle SM; Gorbatiy V; Salas N; Narayanan G; Morillo-Burgos G; Jorda M; Faraday MM
J Endourol; 2013 Apr; 27(4):480-9. PubMed ID: 23098088
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
10. Image guided radiofrequency ablation for small renal masses.
Kelly EF; Leveillee RJ
Int J Surg; 2016 Dec; 36(Pt C):525-532. PubMed ID: 27847290
[TBL] [Abstract][Full Text] [Related]
11. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring.
Wingo MS; Leveillee RJ
J Endourol; 2008 Jun; 22(6):1261-7. PubMed ID: 18484892
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique?
Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J
Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801
[TBL] [Abstract][Full Text] [Related]
13. Management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy.
Bird VG; Carey RI; Ayyathurai R; Bird VY
J Endourol; 2009 Jan; 23(1):81-8. PubMed ID: 19118475
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery.
Castle SM; Gorbatiy V; Ekwenna O; Young E; Leveillee RJ
BJU Int; 2012 Feb; 109(3):384-7. PubMed ID: 22176671
[TBL] [Abstract][Full Text] [Related]
15. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.
Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR
BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594
[TBL] [Abstract][Full Text] [Related]
17. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
18. Split renal function after treatment of small renal masses: comparison between radiofrequency ablation and laparoscopic partial nephrectomy.
Acosta Ruiz V; Båtelsson S; Onkamo E; Wernroth L; Nilsson T; Lönnemark M; Dahlman P; Magnusson A
Acta Radiol; 2021 Sep; 62(9):1248-1256. PubMed ID: 32910686
[TBL] [Abstract][Full Text] [Related]
19. Renal ablation: current management strategies and controversies.
Zhong J; Wah TM
Chin Clin Oncol; 2019 Dec; 8(6):63. PubMed ID: 31968983
[TBL] [Abstract][Full Text] [Related]
20. Cost comparison of nephron-sparing treatments for cT1a renal masses.
Castle SM; Gorbatiy V; Avallone MA; Eldefrawy A; Caulton DE; Leveillee RJ
Urol Oncol; 2013 Oct; 31(7):1327-32. PubMed ID: 22361086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
